Steward Financial Group’s Twist Bioscience TWST Stock Holding History

Steward Financial Group’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1	Closed	–	–	973
2023 Q1	$0	Buy	+1	New	+$22	﹤0.01%	913

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Steward Financial Group's TWST Position: Q2 2023 in Review

Steward Financial Group sold out of Twist Bioscience (TWST) in Q2 2023, closing a stake of 1 share.

Steward Financial Group first reported a position in TWST in Q1 2023 and held it in 1 quarter. The position peaked at $0 in Q1 2023. 193 funds tracked by Wall St. Rank hold TWST as of Q2 2023.

Steward Financial Group reported no remaining Twist Bioscience position as of Q2 2023 after selling out during the quarter.
Steward Financial Group sold 1 Twist Bioscience share in Q2 2023.
Steward Financial Group first reported a position in Twist Bioscience in Q1 2023 and held it in 1 quarter.
Steward Financial Group's Twist Bioscience position peaked at $0 in Q1 2023.
193 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2023.

Based on Steward Financial Group's 13F filing for Q2 2023, filed 7 Aug 2023.